ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 266,88
0,40%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA Teva Pharmaceutical Industries Ltd

17,35
-0,05 (-0,29%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Teva Pharmaceutical Industries Ltd TEVA NYSE Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -0,29% 17,35 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
17,38 17,035 17,40 17,16 17,40
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/6/202413:21IHMARKETNEWSAdobe Soars 15% Pre-Market; Visa and Mastercard Encounter..
04/6/202422:05BWTeva to Present at the Goldman Sachs 45th Annual Global..
01/6/202420:25BWNew Data Provide Schizophrenia Treatment Insights into..
01/6/202420:20BWTeva Presents First Real-World Data from the IMPACT-TD..
30/5/202400:38BWTeva Announces AUSTEDO® XR (deutetrabenazine)..
21/5/202402:25BWTeva and Alvotech Announce SIMLANDI® (adalimumab-ryvk)..
15/5/202414:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202414:30EDGAR2Form 8-K - Current report
15/5/202414:15BWTeva Announces Appointment of Matthew Shields to Executive..
09/5/202413:53IHMARKETNEWSBain Capital in Talks to Acquire PowerSchool; Blackstone..
08/5/202413:00BWTeva Reports First Quarter 2024 Financial Results and..
08/5/202412:30BWTeva and Medincell Announce Positive Phase 3 Efficacy..
03/5/202400:30BWTeva to Present at the 2024 Bank of America Healthcare..
02/5/202414:30BWTeva’s 2023 Healthy Future Report Showcases Renewed..
30/4/202410:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
16/4/202423:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202423:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202414:00BWTeva’s New Real-World Evidence Presented at the 2024 AAN..
11/4/202414:30BWTeva Confirms Efficacy and Safety of AJOVY® (fremanezumab)..
09/4/202422:30BWTeva to Host Conference Call to Discuss First Quarter 2024..
06/4/202419:00BWNew Pharmacokinetic Modeling Data Presented by Teva..
04/4/202414:30BWTeva and mAbxience Announce Strategic Global Licensing..
01/4/202414:30BWClinical Collaboration Agreement between Teva and Launch..
07/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202412:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202413:00BWTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote..
24/2/202402:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
24/2/202402:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..

Dernières Valeurs Consultées

NYSE
TEVA
Teva Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés